DAVITRI
LIVE

Serial Number

79301062

Owner

Overture Life, Inc

Attorney

Lindy M. Herman

Filing Date

Nov 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DAVITRI Trademark

Serial Number: 79301062 • Registration: 7095253

DAVITRI is a trademark filed by Overture Life, Inc on November 23, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Overture Life, Inc (8 trademarks)

50 South Pointe Drive

Entity Type: 03

Trademark Details

Filing Date

November 23, 2020

Registration Date

July 4, 2023

Published for Opposition

May 10, 2022

Goods & Services

Design and testing of new products for others; scientific and technological services, namely, scientific research, medical analysis, biological testing in the fields in-vitro fertilization and in the field of clinical reproduction; Development of testing methods, namely, development of testing specifications and procedures for the medical industry; Conducting clinical trials and clinical studies for others; Computer-aided design of molds, all the aforesaid services for use in connection with In Vitro Fertilization and the field of clinical reproduction only

Apparatus for scientific and laboratory research, namely, time-lapse incubators for embryo culture and embryo assessment for couples undergoing in vitro fertilization and intracytoplasmic sperm injection; educational apparatus and simulators, namely, timelapse incubators for embryo culture and embryo assessment for couples undergoing in vitro fertilization and intracytoplasmic sperm injection; scientific apparatus and instruments, namely, time lapse incubators for automated in vitro fertilization, denudation, embryo culture and embryo/gamete screening; research apparatus and instruments, namely, benchtop incubators for embryo culture and monitoring; laboratory apparatus and instruments, namely, namely, laboratory pipettes, and microfluidic biochips for gamete denudation, fertilization, embryo development and image capture; biochips for research or scientific purposes; fermentation apparatus for laboratory use; integrated software packages, namely, downloadable computer software for use in laboratory automation, all the aforesaid goods for use in connection with In Vitro Fertilization and the field of clinical reproduction only

In-vitro fertilization services; analysis of human tissues for medical treatment; medical analyses for the diagnosis and treatment of people; medical consultancy in the field of pregnancy; medical assistance; medical care; medical consultations; gynecological cytology services; medical examination for persons; medical information; medical analysis services; medical and health services related to DNA, genetics and genetic testing; sperm bank services; human fertility treatment services; pregnancy testing services; all the aforesaid products are intended for exclusive use in relation to in-vitro fertilization and in the field of clinical reproduction

Substance analysis apparatus for medical use, namely, microscopes, benchtop incubators, for use in providing assisted reproductive medical care; pH analyzers; temperature analyzers; sensors used to analyze culture media for pregnancy and miscarriage likelihood; medical diagnostic apparatus for medical use, namely, machines for detecting embryo DNA, metabolites, and proteins; tools for medical diagnosis, namely, mass spectrometers for analyzing biomarkers and identifying metabolomic profiling, genetic blueprint, aneuploidy screening, genetic abnormalities screening for pregnancy and miscarriage likelihood, all the aforesaid services for use in connection with In Vitro Fertilization and the field of clinical reproduction only

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 31, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 5, 2023 FICS
FINAL DISPOSITION PROCESSED
Oct 4, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 4, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 4, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 4, 2023 R.PR
TTAB RELEASE CASE TO TRADEMARKS
May 31, 2023 TMBN
OPPOSITION TERMINATED NO. 999999
May 31, 2023 OP.T
OPPOSITION DISMISSED NO. 999999
May 31, 2023 OP.D
REFUSAL PROCESSED BY IB
Dec 4, 2022 RFNT
POST PUBLICATION AMENDMENT - ENTERED
Nov 22, 2022 CHPB
ASSIGNED TO PETITION STAFF
Nov 21, 2022 APET
OPPOSITION INSTITUTED NO. 999999
Nov 8, 2022 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Nov 7, 2022 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Nov 5, 2022 OPNC
TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 4, 2022 EPPA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 21, 2022 OPNX
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 7, 2022 ETOF
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 1, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 1, 2022 OPNR
NOTIFICATION PROCESSED BY IB
May 16, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 10, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 10, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 20, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 20, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 20, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 2, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 1, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 1, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 1, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 1, 2022 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 28, 2021 GNFN
FINAL REFUSAL E-MAILED
Oct 28, 2021 GNFR
FINAL REFUSAL WRITTEN
Oct 28, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 8, 2021 TROA
REFUSAL PROCESSED BY IB
Apr 25, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 8, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 8, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 6, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 5, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 3, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 6, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 2, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 31, 2020 REPR